“…13,14,30 In addition, Bock et al measured no difference in retinal NFL loss between MS patients and glaucoma patients. 30 However, it is unclear if there is a shared mechanism involved. Male gender is Abbreviations: HR, Hazard Ratio; CI, Confidence Interval; N, number of cataract/glaucoma patients; IV, intravenous *analysis includes free-text information on oral and intravenous exposure during MS relapse # : referent: patients without multiple sclerosis; adjusted for age and gender, smoking, body mass index, hypnotics/anxiolytics, anticonvulsants, antidepressants use 6 months prior, diabetes mellitus, chronic obstructive pulmonary disease, cerebrovascular disease, epilepsy and any ocular surgery ever before & : referent: patients without multiple sclerosis; adjusted for age and gender, smoking, body mass index, anticonvulsants, serotonin-selective reuptake inhibitors, tricyclic antidepressants use 6 months prior, cerebrovascular disease, epilepsy and any uveitis ever before § : π: Statistically significant difference (p < 0.05) of the exposure to oral and intravenous glucocorticoids versus non-exposure to oral and IV glucocorticoids 6 months before ¥ : Statistically significant difference (p < 0.05) of the exposure to systemic glucocorticoids versus non-exposure to systemic glucocorticoids ever before π : Statistically significant difference (p < 0.05) of the exposure to oral and intravenous glucocorticoids versus non-exposure to oral and IV glucocorticoids 6 months before ξ : Statistically significant difference (p < 0.05) of the short-course exposure to oral and intravenous glucocorticoids versus non-short-.course exposure to oral and IV glucocorticoids in the year before φ : Statistically significant difference (p < 0.05) of the short-course exposure to oral glucocorticoids versus intravenous short-course exposure to glucocorticoids in the year before reported to be predictive for progression of glaucomatous disease.…”